Fast Five Quiz: Immunosuppression for Kidney Transplantation

Ron Shapiro, MD


October 22, 2021

Typical antibody-based induction immunosuppression therapy uses antibody preparations directed at T cells in combination with calcineurin inhibitors, antiproliferative agents, and corticosteroids. Calcineurin inhibitors have been a cornerstone of clinical immunosuppression in transplantation since the early 1980s.

PD-1 inhibitors, tyrosine kinase inhibitors, and vascular endothelial growth factor receptor inhibitors are all types of immunotherapies used in the treatment of kidney cancer.

Learn more about immunosuppressive agents used for kidney transplantation.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.